Aclarion, Inc. (ACON)

NASDAQ: ACON · Real-Time Price · USD

3.470

+0.100 (2.97%)

Jun 2, 2026, 2:31 PM EDT - Market open

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
The Delivery of Nociscan Reports	75.73K	45.72K	75.40K	60.44K	60.29K
The Delivery of Nociscan Reports Growth	65.62%	-39.36%	24.75%	0.25%	23.93%
Total	75.73K	45.72K	75.40K	60.44K	60.29K
Total Growth	65.62%	-39.36%	24.75%	0.25%	23.93%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
United States	19.69K	29.72K	65.60K	55.00K	53.66K
United States Growth	-33.75%	-54.70%	19.27%	2.51%	14.89%
outside The United States	56.04K	16.00K	9.80K	5.44K	6.63K
outside The United States Growth	250.18%	63.26%	80.22%	-17.99%	240.80%
Total	75.73K	45.72K	75.40K	60.44K	60.29K
Total Growth	65.63%	-39.36%	24.75%	0.25%	23.93%

Source: S&P Global Market Intelligence.